In the last podcast episode we leave the topic of primary immunodeficiency (PID) and dive with Dr. med. Urs Steiner into the application of Cuvitru®, our subcutaneous immunoglobulin, in the treatment of secondary immunodeficiency (SID), with a focus on the positive effects of Cuvitru® on the patient's quality of life.
Moderator: Dr. med. Marcus Kühn, Specialist in Allergology and clinical Immunology at the Löwenpraxis Lucerne (website).
Guest: PD Dr. med. Urs Steiner, Head Physician at the University hospital for Rheumatology and Immunology, Inselspital, Bern (website)
Brightcove Video
Resources and Links:
[1] Krivan G, Jolles S, Granados EL, Paolantonacci P, Ouaja R, Cissé OA, Bernatowska E. New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients. Am J Clin Exp Immunol. 2017 Nov 1;6(5):76-83. PMID: 29181272; PMCID: PMC5698561.
[2] Devonshire AL, Makhija M. Approach to primary immunodeficiency. Allergy Asthma Proc. 2019 Nov 1;40(6):465-469. doi: 10.2500/aap.2019.40.4273. PMID: 31690396.
Cuvitru®prescribing information: www.swissmedicinfo.ch
Healthcare professionals may request a complete copy of the cited literature from the pharmaceutical company.
C-APROM/CH/CUVI/0103_11/2023